AI-based 3D-QSAR model of FDA-approved repurposed drugs for inhibiting sclerostin.

MLA

Yadalam, Pradeep Kumar, et al. “AI-Based 3D-QSAR Model of FDA-Approved Repurposed Drugs for Inhibiting Sclerostin.” Technology and Health Care : Official Journal of the European Society for Engineering and Medicine, vol. 32, no. 5, 2024, pp. 3007–19. EBSCOhost, https://doi.org/10.3233/THC-231358.

APA

Yadalam, P. K., Anegundi, R. V., Ramadoss, R., Shrivastava, D., Almufarrij, R. A. S., & Srivastava, K. C. (2024). AI-based 3D-QSAR model of FDA-approved repurposed drugs for inhibiting sclerostin. Technology and Health Care : Official Journal of the European Society for Engineering and Medicine, 32(5), 3007–3019. https://doi.org/10.3233/THC-231358

Chicago

Yadalam, Pradeep Kumar, Raghavendra Vamsi Anegundi, Ramya Ramadoss, Deepti Shrivastava, Raha Ahmed Shamikh Almufarrij, and Kumar Chandan Srivastava. 2024. “AI-Based 3D-QSAR Model of FDA-Approved Repurposed Drugs for Inhibiting Sclerostin.” Technology and Health Care : Official Journal of the European Society for Engineering and Medicine 32 (5): 3007–19. doi:10.3233/THC-231358.